Growing Demand Reshape Kidney and Pancreas Transplantation Landscape

Published: Jul 2024

Global kidney and pancreas transplant market is anticipated to grow at a significant CAGR of 9.7% during the forecast period (2024-2031). The high prevalence of blood pressure and diabetes globally, which are the two leading causes of kidney failure, have created global market demand. Additionally, the rising incidence of End-Stage Renal Disease (ESRD), together with improvements in transplant surgery and immunosuppressive medicines is contributing to market growth. Also, the rise in overall healthcare spending and betterment in organ donation percentages across the developing economy is contributing to the expansion of the market.

Browse the full report description of “Kidney and Pancreas Transplant Market Size, Share & Trends Analysis Report by Source (Living Donors, and Deceased Donors), by Treatment (Analgesic, Immunosuppressant, and Others), and by End-User (Hospitals, Transplant Centers, and Others) Forecast Period (2024-2031)” at https://www.omrglobal.com/industry-reports/global-kidney-and-pancreas-transplant-market

According to the Health Resources and Services Administration.gov, there were 13,567 transplants in the US in 2022, broken down by recipient gender. The ease of access to both living and deceased donors at a variety of healthcare facilities, including hospitals and medical centers, is anticipated to boost market expansion shortly. The global kidney and pancreas transplant market is growing as a result of the increasing number of deceased and living donors as well as the high volume of kidney transplants performed. 

In December 2019, the United Network for Organ Sharing (UNOS) implemented a new allocation system for kidney and pancreas transplants, this new system prioritizes kidney and pancreas offers for candidates listed at transplant hospitals within a 250-nautical-mile radius of the donor hospital, and then candidates at transplant hospitals beyond 250 nautical miles. The goal of this policy change was to improve equity in access to kidney and pancreas transplants, especially for key groups like children, ethnic minorities, and candidates who are hard to match biologically. Such initiatives are anticipated to offer lucrative opportunities for global market growth.

Market Coverage

The market number available for – 2023-2031

Base year- 2023

Forecast period- 2024-2031

Segment Covered- 

o By Source

o By Treatment

o By End-Users

Regions Covered-

o North America

o Europe

o Asia-Pacific

o Rest of the World

Competitive Landscape- Baxter Healthcare Corp., Fresenius Medical Care AG & CO. KGaA, and Medtronic PLC among others.

Key questions addressed by the report.

  • What is the market growth rate?
  • Which segment and region dominate the market in the base year?
  • Which segment and region will project the fastest growth in the market?
  • Who is the leader in the market?
  • How are players addressing challenges to sustain growth?
  • Where is the investment opportunity?

Global Kidney and Pancreas Transplant Market Report Segment

By Source

  • Living Donors
  • Deceased Donors

By Treatment

  • Analgesic
  • Immunosuppressant
  • Others (Diuretics and Antihypertensive)

By End-Users

  • Hospitals
  • Transplant Centers
  • Others (Clinics, Outpatient Facilities, and Academic Medical Institutions)

Global Kidney and Pancreas Transplant Market Report Segment by Region

North America

United States

Canada 

Europe

UK

Germany

Italy

Spain

France

Rest of Europe 

Asia-Pacific

China

India

Japan

South Korea

Rest of Asia-Pacific 

Rest of the World

Latin America 

Middle East & Africa


To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/global-kidney-and-pancreas-transplant-market